Dong Bai Jun
Dong Bai Jun — Chief Physician — Urology — Renji Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine (East Campus)
Specialties
Mainly engaged in clinical diagnosis and research of urinary system tumors, especially prostate cancer. Specializes in precise, painless, and targeted puncture of the prostate, robot-assisted/laparoscopic function-preserving radical surgery for prostate cancer, ultra-minimally invasive procedures such as cryoablation/high-energy focused ultrasound/nanoknife, molecular diagnosis and precision diagnosis and treatment of prostate cancer, individualized treatment of neutrophic resistant prostate cancer, comprehensive diagnosis and treatment of neuroendocrine-differentiated prostate cancer, as well as precision diagnosis and treatment of kidney cancer and bladder cancer.
Education
Doctor
Professional Experience
Dong Bojun, PhD, master's supervisor, Chief Physician of the Department of Urology at Renji Hospital affiliated with Shanghai Jiao Tong University School of Medicine, postdoctoral fellow at MD Anderson Cancer Center in the United States, mainly engaged in the clinical diagnosis, treatment, and research of urinary tumors, especially prostate cancer. He is skilled in precise, painless, and targeted prostate puncture, robot-assisted/laparoscopic functional-preserving radical prostatectomy for prostate cancer, ultra-minimally invasive procedures such as prostate cryoablation/high-intensity focused ultrasound/NanoKnife, molecular diagnosis and precision treatment of prostate cancer, individualized treatment of castration-resistant prostate cancer, and comprehensive diagnosis and treatment of neuroendocrine-differentiated prostate cancer. He received the 2017 Shanghai Talent Development Fund, the 2019 Research Physician Grant from the Shanghai Municipal Education Commission High Peak and High Plateau Discipline Construction Program, was named a '2019 Young Talent' by the Urology Branch of the Shanghai Medical Association, awarded the 'People's Good Doctor (Urological Tumor Field) Golden Camellia - Outstanding Contribution' title at the 2020 China Cancer Prevention and Control Annual Conference, and recognized as an MD and MDT Excellent Doctor by the Urological and Male Reproductive Tumor Committee of the China Anti-Cancer Association in 2021 and 2022.
Professional Roles
Member of the Prostate Cancer Expert Committee of the Chinese Society of Clinical Oncology; Deputy Secretary-General of the Urology Branch of the Chinese Geriatrics Society; Member of the Basic Research Group of the Urology Branch of the Chinese Medical Association; Member of the Prostate Cancer Group of the Urological and Male Reproductive Tumor Committee of the Chinese Anti-Cancer Association; Standing Member of the Tumor Multidisciplinary Diagnosis Collaboration Group of the Tumor Marker Committee of the Chinese Anti-Cancer Association; Member of the Tumor Interventional Ablation Expert Committee of the Chinese Anti-Cancer Association; Correspondence Editor of the Chinese Journal of Urology